Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 29;14(6):203-206.
doi: 10.1002/cld.868. eCollection 2019 Dec.

Hepatitis C Virus in Egypt: Interim Report From the World's Largest National Program

Wael Abdel-Razek  1 , Mohamed Hassany  2 , Manal Hamdy El-Sayed  3 , Magdy El-Serafy  4 , Wahid Doss  4 , Gamal Esmat  4 , Imam Waked  1
Affiliations
Review

Hepatitis C Virus in Egypt: Interim Report From the World's Largest National Program

Wael Abdel-Razek et al. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Number of patients registering daily on the web‐based registration system during the first month to be evaluated for DAA therapy (103,258 patients on the first day, 550,000 patients during the first month). (B) Number of patients evaluated monthly for DAA therapy in NCCVH specialized treatment centers (first 580,000 patients evaluated in 6 months). Source: NCCVH, unpublished data.
Figure 2
Figure 2
Payment coverage for DAA therapy until September 2018 (2.4 million patients): 85% funded by the state through different sponsors and 15% funded out of pocket. Source: NCCVH data.
See this image and copyright information in PMC

References

    1. El‐Zanaty F, Way A. Knowledge and prevalence of hepatitis C. Egypt demographic and health survey 2008 . Cairo, Egypt: Ministry of Health, El‐Zanaty and Associates, and Macro International; 2009. Available at: https://dhsprogram.com/pubs/pdf/FR220/FR220.pdf. Accessed January 10, 2019.
    1. Ministry of Health, Egypt, El‐Zanaty and Associates, Egypt, ICF International. Egypt Health Issues Survey . Cairo, Egypt: Ministry of Health and ICF International; 2015.
    1. Blach S, Zeuzem S, Manns M, et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2016;2:161‐176. - PubMed
    1. Abozeid MI, Alsebaey A, Abdel Sameea E, et al. High efficacy of generic and brand direct acting antivirals in treatment of chronic hepatitis C. Int J Infect Dis 2018;75:109‐114. - PubMed
    1. Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis patients with HIV/HCV co‐infection. Hepatology 2006;43:1317‐1325. - PubMed